^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in sterile water for injection.

^d Tested in bacteriostatic sodium chloride 0.9% preserved with benzyl alcohol 0.9%.

^e Test performed using the formulation WITHOUT edetate disodium.

^f Tested in Ringer’s injection, lactated.

^g Lyophilized formulation tested.

^h Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

ⁱ Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.

^j Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.

^k Tested in both dextrose 5% and sodium chloride 0.9%.

^l Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^m Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

ⁿ Test performed using the formulation WITH edetate disodium.

^o Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.

^p Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^q Intralipid product.

^r SMOFlipid product.